InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: None

Wednesday, 11/25/2020 2:56:49 PM

Wednesday, November 25, 2020 2:56:49 PM

Post# of 148
(OT) Catamaran Bio [1] has raised $42M in a Series A. They are working on CAR-NK cells, allogeneic sources (healthy donors), and uses non-viral methods (which allows for multiplexing) to engineer them further for solid tumours [2,3].

Refs:
1 https://catamaranbio.com
2 https://www.isct-cytotherapy.org/article/S1465-3249(16)30631-4/fulltext
3 https://clincancerres.aacrjournals.org/content/25/14/4400.long
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NKTX News